Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ISRCTN59922389) titled 'Optimising the use of azithromycin antibiotic to reduce Bronchiectasis flare-ups' on May 8.
Study Type: Interventional
Study Design:
Randomized placebo-controlled double-blind parallel-group-assignment study (Efficacy)
Primary Sponsor: Newcastle upon Tyne Hospitals NHS Foundation Trust
Condition:
Medical condition: Bronchiectasis
Medical condition in lay language: Bronchiectasis
Therapeutic areas: Diseases [C] - Respiratory Tract Diseases [C08]
Respiratory
Intervention:
The intervention is the continuation of long-term azithromycin compared to a matched placebo. The dose is matched to the patients pre-existi...